English | 简体中文 | 繁體中文 | 한국어 | 日本語
  Press Releases
Wednesday, February 22, 2023
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration
Friday, February 10, 2023
亿胜生物宣布贝伐珠单抗眼科适应症国际多中心III期临床研究完成美国首例患者给药
億勝生物宣佈貝伐珠單抗眼科適應症國際多中心III期臨床研究完成美國首例患者給藥
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases
Thursday, October 13, 2022
亿胜生物成功从Mitotech获得SkQ1眼科领域全球独家权益
億勝生物成功從Mitotech獲得SkQ1眼科領域全球獨家權益
Essex Biotechnology Secures Exclusive Rights and Interests in SkQ1 for Ophthalmology from Mitotech
Tuesday, August 16, 2022
亿胜生物荣登「2022年福布斯亚洲中小上市企业200强」
億勝生物榮登「2022年福布斯亞洲中小上市企業200強」
Essex Bio-Technology Included in "Forbes Asia's Best Under A Billion 2022"

Copyright © 2024 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Cookies Policy | Privacy Policy | Disclaimer | Terms of Use | RSS
US: +1 214 890 4418 | China: +86 181 2376 3721 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575